Afinitor (everolimus)
pCPA File Number:
20802
Negotiation Status:
Negotiations were not pursued
Indication(s):
renal angiomyolipoma associated with tuberous sclerosis complex (TSC)
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0315-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: